Moleculin Biotech, Inc.

Historical 13F Holders

Symbol: MBRX
CUSIP: 60855D309
All holders as of: Q3 2025
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 60855D309 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Armistice Capital, LLC 13G/A Amendment 4	4.99%	1,586,521	13G/A Amendment 4	8/14/2025 Event 6/30/2025
Armistice Capital, LLC	4.99%	1,586,521
Steven Boyd	4.99%	1,586,521
Armistice Capital, LLC 13G/A Amendment 3	8.9%	1,250,000	13G/A Amendment 3	5/15/2025 Event 3/31/2025
Armistice Capital, LLC	8.9%	1,250,000
Steven Boyd	8.9%	1,250,000
Armistice Capital, LLC 13G/A Amendment 2	10.0%	339,767	13G/A Amendment 2	2/14/2025 Event 12/31/2024
Armistice Capital, LLC	10.0%	339,767
Steven Boyd	10.0%	339,767

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q3	25	778 k	$413 k	$0
2025 Q2	24	390 k	$118 k	$0
2025 Q1	24	1.48 M	$1.44 M	$0
2024 Q4	22	465 k	$790 k	$0
2024 Q3	21	461 k	$1.31 M	$0
2024 Q2	19	314 k	$1.11 M	$0
2024 Q1	23	259 k	$1.53 M	$0